PortfoliosLab logoPortfoliosLab logo
DYN vs. SOFI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

DYN vs. SOFI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dyne Therapeutics, Inc. (DYN) and SoFi Technologies, Inc. (SOFI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DYN achieves a -11.86% return, which is significantly higher than SOFI's -32.24% return.


DYN

1D
-7.46%
1M
-0.86%
YTD
-11.86%
6M
-13.76%
1Y
35.75%
3Y*
8.68%
5Y*
-0.88%
10Y*

SOFI

1D
-4.52%
1M
7.97%
YTD
-32.24%
6M
-39.88%
1Y
29.77%
3Y*
36.14%
5Y*
-4.79%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

DYN vs. SOFI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
DYN
Dyne Therapeutics, Inc.
-11.86%-16.98%77.14%14.75%-2.52%-43.38%4.17%
SOFI
SoFi Technologies, Inc.
-32.24%70.00%54.77%115.84%-70.84%27.09%18.70%

Correlation

The correlation between DYN and SOFI is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Dec 1, 2020

0.28

Fundamentals

Market Cap

DYN:

$2.85B

SOFI:

$24.45B

EPS

DYN:

-$3.29

SOFI:

$0.44

PB Ratio

DYN:

3.29

SOFI:

2.26

Total Revenue (TTM)

DYN:

$0.00

SOFI:

$4.73B

Gross Profit (TTM)

DYN:

-$521.00K

SOFI:

$3.39B

EBITDA (TTM)

DYN:

-$441.38M

SOFI:

$1.40B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Dyne Therapeutics, Inc.

SoFi Technologies, Inc.

Return for Risk

DYN vs. SOFI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DYN
DYN Risk / Return Rank: 5858
Overall Rank
DYN Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
DYN Sortino Ratio Rank: 5959
Sortino Ratio Rank
DYN Omega Ratio Rank: 5858
Omega Ratio Rank
DYN Calmar Ratio Rank: 6161
Calmar Ratio Rank
DYN Martin Ratio Rank: 5858
Martin Ratio Rank

SOFI
SOFI Risk / Return Rank: 5555
Overall Rank
SOFI Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
SOFI Sortino Ratio Rank: 5555
Sortino Ratio Rank
SOFI Omega Ratio Rank: 5353
Omega Ratio Rank
SOFI Calmar Ratio Rank: 5555
Calmar Ratio Rank
SOFI Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DYN vs. SOFI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dyne Therapeutics, Inc. (DYN) and SoFi Technologies, Inc. (SOFI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DYNSOFIDifference

Sharpe ratio

Return per unit of total volatility

0.43

0.54

-0.10

Sortino ratio

Return per unit of downside risk

1.26

1.06

+0.21

Omega ratio

Gain probability vs. loss probability

1.16

1.13

+0.03

Calmar ratio

Return relative to maximum drawdown

0.99

0.63

+0.36

Martin ratio

Return relative to average drawdown

1.83

1.21

+0.62

DYN vs. SOFI - Sharpe Ratio Comparison

The current DYN Sharpe Ratio is 0.43, which is comparable to the SOFI Sharpe Ratio of 0.54. The chart below compares the historical Sharpe Ratios of DYN and SOFI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


DYNSOFIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.43

0.54

-0.10

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.01

-0.07

+0.06

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.07

0.14

-0.21

Drawdowns

DYN vs. SOFI - Drawdown Comparison

The maximum DYN drawdown since its inception was -85.52%, roughly equal to the maximum SOFI drawdown of -83.32%. Use the drawdown chart below to compare losses from any high point for DYN and SOFI.


Loading charts...

Drawdown Indicators


DYNSOFIDifference

Max Drawdown

Largest peak-to-trough decline

-85.52%

-83.32%

-2.20%

Max Drawdown (1Y)

Largest decline over 1 year

-44.65%

-52.96%

+8.31%

Max Drawdown (3Y)

Largest decline over 3 years

-85.52%

-52.96%

-32.56%

Max Drawdown (5Y)

Largest decline over 5 years

-85.52%

-82.00%

-3.52%

Current Drawdown

Current decline from peak

-63.35%

-44.92%

-18.43%

Average Drawdown

Average peak-to-trough decline

-50.70%

-51.23%

+0.53%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.10%

27.54%

-3.44%

Volatility

DYN vs. SOFI - Volatility Comparison

Dyne Therapeutics, Inc. (DYN) has a higher volatility of 20.84% compared to SoFi Technologies, Inc. (SOFI) at 14.15%. This indicates that DYN's price experiences larger fluctuations and is considered to be riskier than SOFI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DYNSOFIDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.84%

14.15%

+6.69%

Volatility (6M)

Calculated over the trailing 6-month period

50.07%

37.56%

+12.51%

Volatility (1Y)

Calculated over the trailing 1-year period

83.09%

55.80%

+27.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

79.66%

66.92%

+12.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

78.68%

71.95%

+6.73%

Dividends

DYN vs. SOFI - Dividend Comparison

Neither DYN nor SOFI has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

DYN vs. SOFI - Financials Comparison

This section allows you to compare key financial metrics between Dyne Therapeutics, Inc. and SoFi Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B1.20B1.40B202220232024202520260
1.00B
(DYN) Total Revenue
(SOFI) Total Revenue
Values in USD except per share items

Frequently Asked Questions


DYN and SOFI have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DYN has higher volatility (20.84%) compared to SOFI (14.15%). In terms of maximum drawdown, DYN dropped -85.52% vs SOFI's -83.32%.

SOFI currently has the higher Sharpe Ratio (0.54 vs 0.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DYN and SOFI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer